首页> 美国卫生研究院文献>Molecular Vision >A real-time ARMS PCR/high-resolution melt curve assay for the detection of the three primary mitochondrial mutations in Leber’s hereditary optic neuropathy
【2h】

A real-time ARMS PCR/high-resolution melt curve assay for the detection of the three primary mitochondrial mutations in Leber’s hereditary optic neuropathy

机译:实时ARMS PCR /高分辨率熔解曲线测定法可检测Leber遗传性视神经病变中的三个主要线粒体突变

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

PurposeApproximately 95% of patients who are diagnosed with Leber’s hereditary optic neuropathy (LHON) have one of three mitochondrial point mutations responsible for the disease, G3460A, G11778A, and T14484C. The purpose of this study was to develop a novel multiplex real-time amplification-refractory mutation system (ARMS) PCR combined with high-resolution melt curves to identify the individual mutations involved. The study aimed to provide a more robust, cost- and time-effective mutation detection strategy than that offered with currently available methods. The assay reported in this study will allow diagnostic laboratories to avoid costly next-generation sequencing (NGS) assays for most patients with LHON and to focus resources on patients with unknown mutations that require further analysis.
机译:目的大约95%的被诊断患有Leber遗传性视神经病变(LHON)的患者具有导致该疾病的三种线粒体点突变之一,即G3460A,G11778A和T14484C。这项研究的目的是开发一种结合了高分辨率熔解曲线的新型多重实时扩增-难治性突变系统(ARMS)PCR,以鉴定涉及的单个突变。这项研究旨在提供一种比当前可用方法更强大,成本和时间更有效的突变检测策略。这项研究中报道的检测方法将使诊断实验室能够避免对大多数LHON患者进行昂贵的下一代测序(NGS)检测,并将资源集中在需要进一步分析的未知突变患者上。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号